Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expression
Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furth...
Saved in:
Published in | The Journal of physiology Vol. 589; no. 6; pp. 1409 - 1420 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
15.03.2011
Wiley Subscription Services, Inc Blackwell Science Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise.
The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6. |
---|---|
AbstractList | The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased in serum (2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice. We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6. Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise. Abstract The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6. The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6. Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise. The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6. Non-technical summary Exercise is known to stimulate the production of various exercise factors including the well-described muscle-derived interleukin-6 (IL-6). We show that exercise causes a massive expression of the chemokine CXCL-1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise-induced liver CXCL-1 expression is regulated by IL-6 and that muscle-derived IL-6 is capable of stimulating liver CXCL-1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise. Abstract The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased in serum (2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice. We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6. The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6. |
Author | Adser, Helle Pilegaard, Henriette Hidalgo, Juan Hansen, Jakob Pedersen, Bente Klarlund Brandt, Claus Pedersen, Line Hojman, Pernille Olesen, Jesper |
Author_xml | – sequence: 1 givenname: Line surname: Pedersen fullname: Pedersen, Line – sequence: 2 givenname: Henriette surname: Pilegaard fullname: Pilegaard, Henriette – sequence: 3 givenname: Jakob surname: Hansen fullname: Hansen, Jakob – sequence: 4 givenname: Claus surname: Brandt fullname: Brandt, Claus – sequence: 5 givenname: Helle surname: Adser fullname: Adser, Helle – sequence: 6 givenname: Juan surname: Hidalgo fullname: Hidalgo, Juan – sequence: 7 givenname: Jesper surname: Olesen fullname: Olesen, Jesper – sequence: 8 givenname: Bente Klarlund surname: Pedersen fullname: Pedersen, Bente Klarlund – sequence: 9 givenname: Pernille surname: Hojman fullname: Hojman, Pernille |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21224226$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkstu1DAUhi1URKeFN0AoEgvYpPiWxGGBhEblppFgUSR2lmufMJ4m9tROSmfHI_CMPAlnNB1UugA2tnT8_f_xuRyRgxADEPKY0RPGmHixWi832cf-hFMMcUobIe6RGZN1WzZNKw7IjFLOS9FU7JAc5byilAnatg_IIWecS87rGYmn15Csz_Dz-w8f3GTBFb2_glTYJQzxwgco5l_mC3xmBVyvE2RMGgqfEQsXSI-xGKZs-62Dg4RaV_gwQuphQjlG61vCh-R-Z_oMj27uY_L5zenZ_F25-Pj2_fz1orSVkrLk58pZZl0npK1sRTsllDJdLVvWOCpMXTe8ahV3FdZhpGioUUJ0DiS10nVUHJNXO9_1dD6AsxDGZHq9Tn4waaOj8frPl-CX-mu80oIqzujW4NmNQYqXE-RRDz5b6HsTIE5ZqxpbLgXnSD7_K8lwClWNB0P06R10FacUsBGaVbISQrRKIfXk9t9_f3o_NQRe7gCbYs4JOm39aEZsL5bie8yotyui9yuityuidyuCYnlHvPf_h6zdyb75Hjb_pdFnHz7haKT4BTn22SQ |
CODEN | JPHYA7 |
CitedBy_id | crossref_primary_10_1007_s00223_013_9813_8 crossref_primary_10_3390_ijms19123836 crossref_primary_10_3390_ijms18010008 crossref_primary_10_1152_ajpregu_00373_2016 crossref_primary_10_4103_ijpvm_ijpvm_79_24 crossref_primary_10_1152_ajpregu_00533_2013 crossref_primary_10_3390_nu11071496 crossref_primary_10_3390_metabo13090979 crossref_primary_10_1134_S0022093021040141 crossref_primary_10_3389_fphys_2021_709039 crossref_primary_10_1016_j_jtherbio_2021_102930 crossref_primary_10_1007_s00421_014_3031_6 crossref_primary_10_1111_apha_12975 crossref_primary_10_1371_journal_pone_0092505 crossref_primary_10_1039_C8LC00686E crossref_primary_10_3390_cancers13153820 crossref_primary_10_1016_j_cyto_2017_11_006 crossref_primary_10_1016_j_exger_2015_09_020 crossref_primary_10_1038_nrendo_2012_49 crossref_primary_10_1371_journal_pone_0041719 crossref_primary_10_1016_j_cyto_2012_11_027 crossref_primary_10_1152_ajpendo_00339_2011 crossref_primary_10_1016_j_jare_2022_08_019 crossref_primary_10_1111_j_1748_1716_2011_02373_x crossref_primary_10_1016_j_gendis_2015_10_001 crossref_primary_10_3389_fphys_2022_981577 crossref_primary_10_1371_journal_pone_0084910 crossref_primary_10_3390_ijms23084205 crossref_primary_10_1080_10715762_2017_1291942 crossref_primary_10_3390_jfmk2040035 crossref_primary_10_1139_h11_076 crossref_primary_10_14341_osteo2016128_34 crossref_primary_10_1111_bpa_12071 crossref_primary_10_3390_toxins9070197 crossref_primary_10_1113_expphysiol_2012_068726 crossref_primary_10_14814_phy2_12788 crossref_primary_10_1113_jphysiol_2012_245548 crossref_primary_10_14814_phy2_13519 crossref_primary_10_3390_nu15071729 crossref_primary_10_1016_j_biomaterials_2019_119416 crossref_primary_10_4161_adip_20344 crossref_primary_10_1007_s11010_015_2351_0 crossref_primary_10_1007_s12010_023_04755_9 crossref_primary_10_1016_j_jbc_2022_102686 crossref_primary_10_1016_j_jnutbio_2018_12_003 crossref_primary_10_1007_s00424_019_02332_w crossref_primary_10_7717_peerj_4446 |
Cites_doi | 10.1016/j.cyto.2010.05.002 10.1210/jc.2002-021687 10.1189/jlb.72.1.9 10.2353/ajpath.2009.080350 10.1023/A:1026070911202 10.1016/S0165-5728(99)00266-0 10.1096/fj.06-7301com 10.1096/fj.01-0507fje 10.1038/labinvest.3700435 10.1152/jappl.1997.82.5.1662 10.1152/physrev.90100.2007 10.1113/jphysiol.2004.077610 10.1079/PNS2004338 10.1007/s00125-010-1666-3 10.1155/2010/520258 10.1084/jem.180.6.2039 10.1152/ajpendo.90280.2008 10.1152/japplphysiol.00739.2009 10.1113/expphysiol.2006.034769 10.1074/mcp.M110.002113 10.1038/368339a0 10.1111/j.1432-1033.1988.tb14383.x 10.1016/j.tips.2007.02.002 10.1038/sj.gt.3302951 10.1016/j.virol.2006.08.003 10.1016/S0021-9258(19)84972-4 10.4049/jimmunol.165.9.5269 10.1111/j.1469-7793.2001.00633.x 10.1210/jc.2004-0603 10.1172/JCI37480 |
ContentType | Journal Article |
Copyright | 2011 The Authors. Journal compilation © 2011 The Physiological Society Journal compilation © 2011 The Physiological Society 2011 |
Copyright_xml | – notice: 2011 The Authors. Journal compilation © 2011 The Physiological Society – notice: Journal compilation © 2011 The Physiological Society 2011 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
DOI | 10.1113/jphysiol.2010.200733 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Physical Education Index CrossRef MEDLINE Technology Research Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1469-7793 |
EndPage | 1420 |
ExternalDocumentID | PMC3082100 3374326911 21224226 10_1113_jphysiol_2010_200733 TJP4374 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 0YM 10A 123 18M 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3EH 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABITZ ABIVO ABJNI ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C1A C45 CAG CHEAL COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FA8 FIJ FUBAC G-S G.N GODZA GX1 H.X H13 HF~ HGLYW HZI HZ~ H~9 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NEJ NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K RIG ROL RPM RX1 SAMSI SUPJJ TEORI TLM TN5 TR2 UB1 UKR UPT V8K VH1 W8F W8V W99 WBKPD WH7 WHG WIH WIJ WIK WIN WNSPC WOHZO WOQ WOW WQJ WRC WXI WXSBR WYISQ X7M XG1 XOL YBU YHG YKV YQT YSK YXB YYP YZZ ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c5844-2b8dc1cdf34c5c50f8388af64917d03a66725982d5242a4370a833fde40c4df03 |
IEDL.DBID | DR2 |
ISSN | 0022-3751 1469-7793 |
IngestDate | Thu Aug 21 13:59:51 EDT 2025 Fri Jul 11 15:05:39 EDT 2025 Fri Jul 11 02:35:22 EDT 2025 Fri Jul 25 12:11:38 EDT 2025 Wed Feb 19 01:48:22 EST 2025 Tue Jul 01 04:29:00 EDT 2025 Thu Apr 24 23:08:11 EDT 2025 Wed Jan 22 17:09:07 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5844-2b8dc1cdf34c5c50f8388af64917d03a66725982d5242a4370a833fde40c4df03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3082100 |
PMID | 21224226 |
PQID | 1545333988 |
PQPubID | 1086388 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3082100 proquest_miscellaneous_862004322 proquest_miscellaneous_1022560221 proquest_journals_1545333988 pubmed_primary_21224226 crossref_citationtrail_10_1113_jphysiol_2010_200733 crossref_primary_10_1113_jphysiol_2010_200733 wiley_primary_10_1113_jphysiol_2010_200733_TJP4374 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-03-15 |
PublicationDateYYYYMMDD | 2011-03-15 |
PublicationDate_xml | – month: 03 year: 2011 text: 2011-03-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: London |
PublicationTitle | The Journal of physiology |
PublicationTitleAlternate | J Physiol |
PublicationYear | 2011 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc Blackwell Science Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc – name: Blackwell Science Inc |
References | 2004; 63 2010; 53 2010; 2010 1997; 82 2002; 72 2004; 89 2007; 92 2009; 174 2004; 1 2009; 119 2007; 14 2007; 28 2006; 86 2007; 358 1994; 368 2005; 563 2000; 104 1994; 180 1989; 264 2003; 24 1988; 177 2001; 15 2000; 165 2008; 88 2009; 107 2001; 537 2007; 21 2008; 295 2010; 51 2010; 9 2003; 88 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 Le Y (e_1_2_6_16_1) 2004; 1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 15531514 - J Clin Endocrinol Metab. 2004 Nov;89(11):5577-82 11731593 - J Physiol. 2001 Dec 1;537(Pt 2):633-9 15618276 - J Physiol. 2005 Mar 1;563(Pt 2):507-16 20621720 - Cytokine. 2010 Aug;51(2):195-201 20631206 - Mol Cell Proteomics. 2010 Nov;9(11):2482-96 19451693 - J Clin Invest. 2009 Jun;119(6):1571-82 19095949 - Am J Pathol. 2009 Jan;174(1):164-76 3263918 - Eur J Biochem. 1988 Nov 1;177(2):357-61 20224659 - J Biomed Biotechnol. 2010;2010:520258 14609022 - J Muscle Res Cell Motil. 2003;24(2-3):113-9 8127368 - Nature. 1994 Mar 24;368(6469):339-42 17331593 - Trends Pharmacol Sci. 2007 Apr;28(4):152-6 J Physiol. 2012 Dec 15;590(Pt 24):6425 7964481 - J Exp Med. 1994 Dec 1;180(6):2039-48 17030560 - Exp Physiol. 2007 Jan;92(1):233-40 18780777 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1191-204 11687509 - FASEB J. 2001 Dec;15(14):2748-50 11046061 - J Immunol. 2000 Nov 1;165(9):5269-77 10683519 - J Neuroimmunol. 2000 Apr 3;104(1):92-7 17410179 - Gene Ther. 2007 Jun;14(12):950-9 20195842 - Diabetologia. 2010 Jun;53(6):1131-41 16996102 - Virology. 2007 Feb 5;358(1):98-108 16212895 - Cell Mol Immunol. 2004 Apr;1(2):95-104 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406 12101257 - J Leukoc Biol. 2002 Jul;72(1):9-18 2917992 - J Biol Chem. 1989 Mar 5;264(7):4133-7 16715102 - Lab Invest. 2006 Aug;86(8):800-14 15294041 - Proc Nutr Soc. 2004 May;63(2):263-7 19850730 - J Appl Physiol (1985). 2009 Dec;107(6):1830-9 9134917 - J Appl Physiol (1985). 1997 May;82(5):1662-7 17227950 - FASEB J. 2007 Apr;21(4):1026-36 12843134 - J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10 |
References_xml | – volume: 174 start-page: 164 year: 2009 end-page: 176 article-title: Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1 publication-title: Am J Pathol – volume: 563 start-page: 507 year: 2005 end-page: 516 article-title: Exercise induces interleukin‐8 expression in human skeletal muscle publication-title: J Physiol – volume: 368 start-page: 339 year: 1994 end-page: 342 article-title: Impaired immune and acute‐phase responses in interleukin‐6‐deficient mice publication-title: Nature – volume: 24 start-page: 113 year: 2003 end-page: 119 article-title: Searching for the exercise factor: is IL‐6 a candidate? publication-title: J Muscle Res Cell Motil – volume: 107 start-page: 1830 year: 2009 end-page: 1839 article-title: Control of gluconeogenic genes during intense/prolonged exercise: hormone‐independent effect of muscle‐derived IL‐6 on hepatic tissue and PEPCK mRNA publication-title: J Appl Physiol – volume: 537 start-page: 633 year: 2001 end-page: 639 article-title: Interleukin‐6 production in contracting human skeletal muscle is influenced by pre‐exercise muscle glycogen content publication-title: J Physiol – volume: 92 start-page: 233 year: 2007 end-page: 240 article-title: Exercise induces interleukin‐8 receptor. (CXCR2) expression in human skeletal muscle publication-title: Exp Physiol – volume: 358 start-page: 98 year: 2007 end-page: 108 article-title: Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler publication-title: Virology – volume: 89 start-page: 5577 year: 2004 end-page: 5582 article-title: Interleukin‐6 regulates human adipose tissue lipid metabolism and leptin production publication-title: J Clin Endocrinol Metab – volume: 63 start-page: 263 year: 2004 end-page: 267 article-title: The metabolic role of IL‐6 produced during exercise: is IL‐6 an exercise factor? publication-title: Proc Nutr Soc – volume: 72 start-page: 9 year: 2002 end-page: 18 article-title: Role of CXCL1 in tumorigenesis of melanoma publication-title: J Leukoc Biol – volume: 86 start-page: 800 year: 2006 end-page: 814 article-title: Cytokine‐induced neutrophil chemoattractant‐1 is released by the noninjured liver in a rat acute‐phase model publication-title: Lab Invest – volume: 21 start-page: 1026 year: 2007 end-page: 1036 article-title: Enhanced CXCL1 production and angiogenesis in adenosine‐mediated lung disease publication-title: FASEB J – volume: 14 start-page: 950 year: 2007 end-page: 959 article-title: Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation publication-title: Gene Ther – volume: 15 start-page: 2748 year: 2001 end-page: 2750 article-title: Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content publication-title: FASEB J – volume: 295 start-page: E1191 year: 2008 end-page: E1204 article-title: Contractile C2C12 myotube model for studying exercise‐inducible responses in skeletal muscle publication-title: Am J Physiol Endocrinol Metab – volume: 104 start-page: 92 year: 2000 end-page: 97 article-title: Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis publication-title: J Neuroimmunol – volume: 264 start-page: 4133 year: 1989 end-page: 4137 article-title: The platelet‐derived growth factor‐inducible KC gene encodes a secretory protein related to platelet α‐granule proteins publication-title: J Biol Chem – volume: 177 start-page: 357 year: 1988 end-page: 361 article-title: Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte‐stimulating factor in the rat publication-title: Eur J Biochem – volume: 53 start-page: 1131 year: 2010 end-page: 1141 article-title: Activation of the mitogen‐activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise publication-title: Diabetologia – volume: 82 start-page: 1662 year: 1997 end-page: 1667 article-title: Carbohydrate and the cytokine response to 2.5 h of running publication-title: J Appl Physiol – volume: 9 start-page: 2482 year: 2010 end-page: 2496 article-title: Dynamics of the skeletal muscle secretome during myoblast differentiation publication-title: Mol Cell Proteomics – volume: 2010 start-page: 520258 year: 2010 article-title: The role of exercise‐induced myokines in muscle homeostasis and the defense against chronic diseases publication-title: J Biomed Biotechnol – volume: 180 start-page: 2039 year: 1994 end-page: 2048 article-title: Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells publication-title: J Exp Med – volume: 88 start-page: 1379 year: 2008 end-page: 1406 article-title: Muscle as an endocrine organ: focus on muscle‐derived interleukin‐6 publication-title: Physiol Rev – volume: 1 start-page: 95 year: 2004 end-page: 104 article-title: Chemokines and chemokine receptors: their manifold roles in homeostasis and disease publication-title: Cell Mol Immunol – volume: 51 start-page: 195 year: 2010 end-page: 201 article-title: Autocrine IL‐6 regulates GRO‐α production in thymic epithelial cells publication-title: Cytokine – volume: 119 start-page: 1571 year: 2009 end-page: 1582 article-title: Abrogation of TGF‐β signaling enhances chemokine production and correlates with prognosis in human breast cancer publication-title: J Clin Invest – volume: 88 start-page: 3005 year: 2003 end-page: 3010 article-title: Interleukin‐6 stimulates lipolysis and fat oxidation in humans publication-title: J Clin Endocrinol Metab – volume: 165 start-page: 5269 year: 2000 end-page: 5277 article-title: The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR CXC chemokine‐induced angiogenic activity publication-title: J Immunol – volume: 28 start-page: 152 year: 2007 end-page: 156 article-title: Beneficial health effects of exercise – the role of IL‐6 as a myokine publication-title: Trends Pharmacol Sci – ident: e_1_2_6_31_1 doi: 10.1016/j.cyto.2010.05.002 – ident: e_1_2_6_32_1 doi: 10.1210/jc.2002-021687 – ident: e_1_2_6_9_1 doi: 10.1189/jlb.72.1.9 – ident: e_1_2_6_21_1 doi: 10.2353/ajpath.2009.080350 – ident: e_1_2_6_25_1 doi: 10.1023/A:1026070911202 – ident: e_1_2_6_4_1 doi: 10.1016/S0165-5728(99)00266-0 – ident: e_1_2_6_18_1 doi: 10.1096/fj.06-7301com – ident: e_1_2_6_14_1 doi: 10.1096/fj.01-0507fje – ident: e_1_2_6_28_1 doi: 10.1038/labinvest.3700435 – ident: e_1_2_6_20_1 doi: 10.1152/jappl.1997.82.5.1662 – ident: e_1_2_6_23_1 doi: 10.1152/physrev.90100.2007 – ident: e_1_2_6_3_1 doi: 10.1113/jphysiol.2004.077610 – ident: e_1_2_6_26_1 doi: 10.1079/PNS2004338 – ident: e_1_2_6_12_1 doi: 10.1007/s00125-010-1666-3 – volume: 1 start-page: 95 year: 2004 ident: e_1_2_6_16_1 article-title: Chemokines and chemokine receptors: their manifold roles in homeostasis and disease publication-title: Cell Mol Immunol – ident: e_1_2_6_7_1 doi: 10.1155/2010/520258 – ident: e_1_2_6_17_1 doi: 10.1084/jem.180.6.2039 – ident: e_1_2_6_19_1 doi: 10.1152/ajpendo.90280.2008 – ident: e_1_2_6_5_1 doi: 10.1152/japplphysiol.00739.2009 – ident: e_1_2_6_10_1 doi: 10.1113/expphysiol.2006.034769 – ident: e_1_2_6_11_1 doi: 10.1074/mcp.M110.002113 – ident: e_1_2_6_15_1 doi: 10.1038/368339a0 – ident: e_1_2_6_8_1 doi: 10.1111/j.1432-1033.1988.tb14383.x – ident: e_1_2_6_24_1 doi: 10.1016/j.tips.2007.02.002 – ident: e_1_2_6_13_1 doi: 10.1038/sj.gt.3302951 – ident: e_1_2_6_27_1 doi: 10.1016/j.virol.2006.08.003 – ident: e_1_2_6_22_1 doi: 10.1016/S0021-9258(19)84972-4 – ident: e_1_2_6_2_1 doi: 10.4049/jimmunol.165.9.5269 – ident: e_1_2_6_29_1 doi: 10.1111/j.1469-7793.2001.00633.x – ident: e_1_2_6_30_1 doi: 10.1210/jc.2004-0603 – ident: e_1_2_6_6_1 doi: 10.1172/JCI37480 – reference: 20224659 - J Biomed Biotechnol. 2010;2010:520258 – reference: 19850730 - J Appl Physiol (1985). 2009 Dec;107(6):1830-9 – reference: 18780777 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1191-204 – reference: 15618276 - J Physiol. 2005 Mar 1;563(Pt 2):507-16 – reference: 17331593 - Trends Pharmacol Sci. 2007 Apr;28(4):152-6 – reference: 15531514 - J Clin Endocrinol Metab. 2004 Nov;89(11):5577-82 – reference: 9134917 - J Appl Physiol (1985). 1997 May;82(5):1662-7 – reference: 14609022 - J Muscle Res Cell Motil. 2003;24(2-3):113-9 – reference: 17410179 - Gene Ther. 2007 Jun;14(12):950-9 – reference: 17030560 - Exp Physiol. 2007 Jan;92(1):233-40 – reference: 20631206 - Mol Cell Proteomics. 2010 Nov;9(11):2482-96 – reference: 19095949 - Am J Pathol. 2009 Jan;174(1):164-76 – reference: 17227950 - FASEB J. 2007 Apr;21(4):1026-36 – reference: 11731593 - J Physiol. 2001 Dec 1;537(Pt 2):633-9 – reference: 10683519 - J Neuroimmunol. 2000 Apr 3;104(1):92-7 – reference: 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406 – reference: 12843134 - J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10 – reference: 2917992 - J Biol Chem. 1989 Mar 5;264(7):4133-7 – reference: 19451693 - J Clin Invest. 2009 Jun;119(6):1571-82 – reference: 3263918 - Eur J Biochem. 1988 Nov 1;177(2):357-61 – reference: 16996102 - Virology. 2007 Feb 5;358(1):98-108 – reference: 11687509 - FASEB J. 2001 Dec;15(14):2748-50 – reference: 8127368 - Nature. 1994 Mar 24;368(6469):339-42 – reference: 11046061 - J Immunol. 2000 Nov 1;165(9):5269-77 – reference: 12101257 - J Leukoc Biol. 2002 Jul;72(1):9-18 – reference: 20195842 - Diabetologia. 2010 Jun;53(6):1131-41 – reference: 16715102 - Lab Invest. 2006 Aug;86(8):800-14 – reference: 15294041 - Proc Nutr Soc. 2004 May;63(2):263-7 – reference: 7964481 - J Exp Med. 1994 Dec 1;180(6):2039-48 – reference: 16212895 - Cell Mol Immunol. 2004 Apr;1(2):95-104 – reference: 20621720 - Cytokine. 2010 Aug;51(2):195-201 – reference: - J Physiol. 2012 Dec 15;590(Pt 24):6425 |
SSID | ssj0013099 |
Score | 2.2397184 |
Snippet | Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6... Non‐technical summary Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6... The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil... Non-technical summary Exercise is known to stimulate the production of various exercise factors including the well-described muscle-derived interleukin-6... The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1409 |
SubjectTerms | Animal subjects Animals Blood Chemokine CXCL1 - biosynthesis Chemokines Chemokines - biosynthesis Cytokines Exercise physiology Exercise Test - methods Fasting - metabolism Gene Expression Regulation Inflammation Interleukin-6 - biosynthesis Knowledge Liver Liver - metabolism Male Mice Mice, Inbred C57BL Mice, Knockout Muscle, Skeletal - metabolism Muscles (exercise effects) Physical Conditioning, Animal - methods Physical Exertion - physiology Rodents Skeletal Muscle and Exercise |
Title | Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expression |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1113%2Fjphysiol.2010.200733 https://www.ncbi.nlm.nih.gov/pubmed/21224226 https://www.proquest.com/docview/1545333988 https://www.proquest.com/docview/1022560221 https://www.proquest.com/docview/862004322 https://pubmed.ncbi.nlm.nih.gov/PMC3082100 |
Volume | 589 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VPXHhVR4ppTIS4ubi-JE4x2rVVVUBqlAr7S1K7LiU7iaou0GUEz-B38gvYRwnoUtBILjaM0lszzjf2OPPAM-1MsYmTlLhYkOlyhzNnGI0xUJE-4VNtT_v_PpNcngqj2ZqtgHT4SxM4IcYF9y8Z3TztXfwouxvIYk92cD7LvRv5iE9i3e3D-JU7NO2PDZ6y39sJrAsG0nDUxX3J-jwMS9_9ZD1P9QN2Hkze_I6qu1-S9M7cDY0KGSjXOy1q3LPfP6J6_H_W3wXbvfIlewHU7sHG1V9H7b2a4zaF1fkBTkOas3Z1RY0B_1NTt--fMWgH83HkrnPACFoI4vmAj-FTGaTV1gdk-pTn4xbk_Ml8TvKKL1qyKJd4otQxKKXfMQyT21xOa9aVMfS5JriAzidHpxMDml_tQM1iHgk5aW2JjbWCWmUUcxpoXXhEonRo2WiSJKUe2pBqxBCFFKkrNBCOFtJZqR1TDyEzbqpq8dALC-5qHyYhP5eKlGaonK8LJmMbSp0EYEYhjM3Pe-5v35jnof4R-RDv-a-X_PQrxHQUetD4P34g_zOYCl5Pwsscw9PhRCZ1hE8G6vRf_2mTFFXTYsyaJWIOjmPIyC_kcGos6NO5BE8CrY3fhP3O6MIoSNI16xyFPD04es19fm7jkbcExXFjEXAO6P7q2bmJ0fHOBpy-1-UnsCtsCIvaKx2YHN12VZPEdKtyt3OYXe7tbbv9n5Now |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VcoALr_IIFDAS4pbi-JF4j9WqZSnbqkJbaW9RYse0dDdB3Q2inPgJ_EZ-CeM4CV0KAiGu9kwSOzPJN_b4G4DnSmptYitCbiMdCjmw4cBKGibYiGg_M4ly5533D-LRkdibyukavOrOwnh-iH7BzXlG8712Du4WpFsvd2wD75vYv5r5_CzWlB-8Alddce8mtnrLfmwn0MGgpw1PZNSeocPrvPzVVVb_UZeA5-X8yYu4tvkx7d6E425IPh_ldKte5lv6809sj_9hzLfgRgteyba3ttuwVpR3YGO7xMB9fk5ekEOvVr0734Bqpy3m9O3LV4z70YIMmbkkEIJmMq9O8VnIcDocY3dEik9tPm5JThbEbSqj9LIi83qBN0IRg47yEdscu8XZrKhRHVvjC4p34Wh3ZzIchW11h1Aj6BEhy5XRkTaWCy21pFZxpTIbCwwgDeVZHCfMsQsaiSgiEzyhmeLcmkJQLYyl_B6sl1VZPABiWM544SIldPlc8lxnhWV5TkVkEq6yAHj3PlPdUp-7Chyz1IdAPO3mNXXzmvp5DSDstT546o8_yG92ppK2H4JF6hAq53ygVADP-m50Ybcvk5VFVaMMmiUCT8aiAMhvZDDwbNgTWQD3vfH1z8Tc5iii6ACSFbPsBRyD-GpPeXLcMIk7rqKI0gBYY3V_Ncx0sneIb0M8_Belp3BtNNkfp-PXB28ewXW_QM_DSG7C-vKsLh4jwlvmTxrv_Q6uIlCu |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIiEuvMojUMBIiFuK40fiPVbbrkop1Qq10t6ixI7b0t2k6m4Q5cRP4DfySxjHSehSEAiu9kwSOzP2N_b4M8BLJbU2sRUht5EOhRzYcGAlDRMsRLSfmUS5887v9uOdQ7E7kZMVGHVnYTw_RL_g5jyjGa-dg58Z2zq5Ixv40IT-1dSnZ7Hm9sFrcF3EVDnr3nrPfuwm0MGgZw1PZNQeocPnvP7VU5anqCu482r65GVY28xLo9tw1LXIp6OcbtSLfEN__ons8f-bfAdutdCVbHpbuwsrRXkP1jZLDNtnF-QVGXu16uhiDart9iqnb1--YtSP9mPI1KWAEDSSWXWKn0KGk-EeVkek-NRm45bkZE7cljJKLyoyq-f4IhQx6CYfscxxW5xPixrVsTS-pHgfDkfbB8OdsL3bIdQIeUTIcmV0pI3lQkstqVVcqczGAsNHQ3kWxwlz3IJGIobIBE9opji3phBUC2MpfwCrZVUWj4AYljNeuDgJHT6XPNdZYVmeUxGZhKssAN79zlS3xOfu_o1p6gMgnnb9mrp-TX2_BhD2Wmee-OMP8uudpaTtMDBPHT7lnA-UCuBFX40O7HZlsrKoapRBq0TYyVgUAPmNDIadDXciC-Cht73-m5jbGkUMHUCyZJW9gOMPX64pT44bHnHHVBRRGgBrjO6vmpke7I7xb4jH_6L0HG6Mt0bp3pv9t0_gpl-d52Ek12F1cV4XTxHeLfJnje9-B7I5T2Y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exercise-induced+liver+chemokine+CXCL-1+expression+is+linked+to+muscle-derived+interleukin-6+expression&rft.jtitle=The+Journal+of+physiology&rft.au=Pedersen%2C+Line&rft.au=Pilegaard%2C+Henriette&rft.au=Hansen%2C+Jakob&rft.au=Brandt%2C+Claus&rft.date=2011-03-15&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0022-3751&rft.eissn=1469-7793&rft.volume=589&rft.issue=6&rft.spage=1409&rft_id=info:doi/10.1113%2Fjphysiol.2010.200733&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3374326911 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3751&client=summon |